Interview with Martin Pall

Posted on Aug 12, 2009 by Susie Collins in Blog, MCS, Research, Susie Collins

Biochemist Martin Pall talks about his research into the role of toxic chemicals initiating Multiple Chemical Sensitivity.

ProHealth interviews Martin Pall, Ph.D., professor emeritus of biochemistry and basic medical sciences at Washington State University, whose research shows the role of chemicals acting as toxicants in initiating cases of Multiple Chemical Sensitivity.

Professor Pall started looking into Chronic Fatigue Syndrome/Myalgic Encephalomyelitis after he was diagnosed with it. His groundbreaking research into a common cause for CFS/ME, MCS, Fibromyalgia and Post-Traumatic Stress Disorder led to his theory that short-term stressors cause a build up of naturally occurring nitric oxide, which starts a vicious cycle and leads to long-term illness. He calls this the NO/ONOO cycle.

Q&A with Martin Pall, PhD, on the Evidence that MCS is a Toxicological Illness
August 4, 2009

Martin L. Pall, PhD, Professor Emeritus of biochemistry and basic medical sciences at Washington State University, is adding to the science of toxicology with a new research-based paper, “Multiple Chemical Sensitivity: Toxicological and Sensitivity Mechanisms.” Here he is kind enough to summarize and explain his findings for ProHealth.com readers.
___________________

Q: Dr. Pall, we were very encouraged to learn that you have a new evidence-based paper on multiple chemical sensitivity (MCS) that will be published in a prestigious toxicology book. How important is this for patients?

Martin L Pall: The article will be published in an important reference source for professional toxicologists – General and Applied Toxicology, 3rd Edition, part of a multivolume set.

This is a very important paper for several reasons.

• The toxicologists have largely ignored MCS, despite its high prevalence and major impact on human health. So this is an important recognition that MCS is a toxicological phenomenon, a response to chemicals acting as toxicants.

• Furthermore, the fact that I was asked to write it is important recognition for my own earlier work on MCS.

• It is also important to note that the three editors of this set – Drs. Bryan Ballantyne, Timothy C. Marrs, and Tore Syversen – each has distinguished publication records in toxicology. And each of the three has published on chemicals implicated in initiating cases of MCS.

Therefore, I think you can be assured that if there were major flaws in the case that I make that MCS is a toxicological phenomenon, they would certainly have detected them.

Read the rest of the interview.